최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓口腔顎顔面外科學會誌 = Journal of the Korean Association of Oral and Maxillofacial Surgeons, v.36 no.3, 2010년, pp.206 - 210
유경하 (인제대학교 상계백병원 구강악안면외과학교실) , 윤규호 (인제대학교 상계백병원 구강악안면외과학교실) , 배정호 (인제대학교 상계백병원 구강악안면외과학교실) , 박재안 (인제대학교 상계백병원 구강악안면외과학교실) , 박군찬 (인제대학교 상계백병원 구강악안면외과학교실) , 신재명 (인제대학교 일산백병원 구강악안면외과학교실) , 백지선 (인제대학교 일산백병원 구강악안면외과학교실) , 정정권 (인제대학교 상계백병원 구강악안면외과학교실)
Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus, considerat...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
보존적 치료에는 무엇을 포함하는가? | 가급적 보존적 치료를 시행하고 보존적 처치가 반응하지 않을 때 외과적 방법을 생각하는 것을 권고하고 있다10. 보존적 치료에는 0.12% chlorhexidin 같은 외용액의 사용이나 항생제 투여를 포함한다. 골노출이 존재하지만 감염의 증거가 없고 통증이 없다면 하루 3번씩 30 mL 0. | |
Bisphosphonate는 어떤 작용을 하는가? | Bisphosphonate는 파골세포의 활성을 감소시켜 골흡수를 억제하는 작용을 한다고 알려져 있다. 따라서 내과 영역에서 골다공증에서의 골밀도 증가를 위해 사용되어 왔으며 악성종양으로 인한 고칼슘혈증의 치료제로서도 널리 쓰이는 약제이다1. | |
Bisphosphonate어디에 쓰이는가? | Bisphosphonate는 파골세포의 활성을 감소시켜 골흡수를 억제하는 작용을 한다고 알려져 있다. 따라서 내과 영역에서 골다공증에서의 골밀도 증가를 위해 사용되어 왔으며 악성종양으로 인한 고칼슘혈증의 치료제로서도 널리 쓰이는 약제이다1. 하지만 2003년 Marx2가 장기간 bisphosphonate를 정맥주사로 투여받은 환자의 발치 후 악골괴사가 발생한 증례를 발표하면서 구강악안면 영역에서의 bisphosphonate의 합병증에 대한 관심이 커지고 있다. |
Owens G, Jackson R, Lewiecki EM. An integrated approach: bisphosphonate management for treatment of osteoporosis. Am J Manag Care 2007;13 Suppl 11:S290-308.
Marx RE. Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.
Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development. J Oral Maxillofac Surg 2009;67(5 Suppl 1):13-8.
Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007;86:1013-21.
Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007;65:415-23.
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76.
The Korean Endocrine Society, the Korean Society of Bone Metabolism, the Korean Society of Osteoporosis, the Korean Association of Oral and Maxillofacial Surgeons. Bisphosphonate related osteonecrosis of the jaw (BRONJ)-position statement of Korea. J Korean Endocr Soc 2009;24:227-30.
Ohe JY, Kwon YD, Kim YG, Lee BS. Yoon BW, Choi BJ. Features of histologic and radiographic findings in bisphosphonate- related osteonecrosis of jaw-clinical review. J Korean Assoc Oral Maxillofac Surg 2008;34:550-4.
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009;67(5 Suppl):2-12.
Kwon YD, Yoon BW, Walter C. Bispohspohonate, is it an emerging risk factor in oral surgery? J Korean Assoc Maxillofac Plast Reconstr Surg 2007;29:456-62.
Siddiqi A, Payne AG, Zafar S. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e1-8.
Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates- histomorphologic analysis in comparison with infected osteonecrosis. J Oral Pathol Med 2006;35:155-60.
Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005;136:1658-68.
Sawatari Y, Marx RE. Bisphosphonates and bisphosphonate induced osteonecrosis. Oral Maxillofac Surg Clin North Am 2007;19:487-98.
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a reviews of 63 cases. J Oral Maxillofac Surg 2004;62: 527-34.
Chaudhry AN, Ruggiero SL. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery. Oral Maxillofac Surg Clin North Am 2007;19:199-206.
Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced exposed bone (osteonecrosis/osteopetrosis)of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-75.
Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a singlecenter study of 101 patients. J Oral Maxillofac Surg 2009;67: 850-5.
Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 2009; 67:1904-13.
Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:433-41.
Tirelli G, Biasotto M, Chiandussi S, Dore F, de Nardi E, di Lenarda R, et al. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach. Head Neck 2009; 31:1249-54.
Stanton DC, Balasanian E. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg 2009;67:943-50.
Arce K, Assael LA, Weissman JL, Makiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009;67(5 Suppl):75-84.
Wutzl A, Biedermann E, Wanschitz F, Seemann R, Klug C, Baumann A, et al. Treatement results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 2008;30:1224-30.
Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67(5 Suppl):85-95.
Freiberger JJ. Utility of hyperbaric oxygen in treatment of bisphosphonate- related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67(5 Suppl):96-106.
Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R, Lo Muzio L. Case 2. Osteoenecrosis of the jaws associated with bisphosphonate therapy. J Clin Oncol 2006;24:1475-7.
Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos l, Antoniadis K, et al. Osteoenecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 2007;28:158-63.
Nastro E, Musolino C, Allegra A, Oteri G, Cicciu M, Alonci A, et al. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. Acta Haematol 2007;117:181-7.
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al.; American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-91.
Assael LA. Oral bisphosphonates as a cause of bisphosphonaterelated osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 2009; 67(5 Suppl):35-43.
Dodson TB. Intravenous bisphosphonate therapy and bisphosphonate- related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67(5 Suppl):44-52.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.